Trial Profile
Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of Direct Venous Inoculation of Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in HIV Negative and HIV Positive Tanzanian Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Apr 2024
Price :
$35
*
At a glance
- Drugs Malaria vaccine live attenuated-Sanaria (Primary)
- Indications Falciparum malaria
- Focus Adverse reactions
- Sponsors Sanaria
- 03 Apr 2019 Status changed from recruiting to completed.
- 11 Oct 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Oct 2018.
- 17 Sep 2018 Planned End Date changed from 30 Sep 2018 to 30 Oct 2018.